Clinical trial Recruiting at 1 site Interventional Ages 40 to 70

Vestibular-Driven Balance Training vs Dual Task Training for Balance in Chronic Stroke Survivors

Official title: Effects of Vestibular-Oriented Balance Training Versus Motor Dual Task Training on Balance, Postural Control, and Fall Risk in Chronic Stroke SurvivorsIIUI/RERC

Run by Ibadat International University, Islamabad · NCT07754747 · Data updated 2026-11-12

This randomized trial tests whether vestibular-oriented balance training or motor dual task training better improves balance and reduces fall risk in adults with chronic stroke.

Quick facts

Study typeInterventional
Ages40 Years to 70 Years
SexAll
Enrollment50 (estimated)
SponsorIbadat International University, Islamabad
Academic / other
Locations1 site (Rawalpindi)
StatusRecruiting
StartedJuly 10, 2026
Main results expectedNovember 15, 2026
Study endsDecember 18, 2026
Registry record updatedAugust 10, 2026
Trial IDNCT07754747 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 40–70 with ischemic stroke, at least six months post-stroke, able to walk with or without aid, and with MMSE ≥ 24.

Probably not a fit

Patients with acute or subacute stroke, significant visual balance impairments, uncontrolled hypertension or diabetes, other neurological conditions, or inability to participate may derive less or no benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized controlled trial compares two rehabilitation approaches for chronic stroke survivors: Vestibular-Oriented Balance Training (VOBT) and Motor Dual Task Training. Forty-six participants, diagnosed with ischemic stroke and at least six months post-event, will be randomized to receive six weeks of either VOBT or motor dual task training in addition to conventional physiotherapy. Outcomes will be measured with the Biodex Balance System indices and the Modified Clinical Test for Sensory Interaction in Balance to assess overall stability, directional stability, and fall risk. The study seeks to determine which intervention more effectively enhances postural control and reduces fall risk in this population.

Why it matters

Potential benefit: If successful, the preferred training could become a more effective option to improve balance and reduce falls for chronic stroke patients.

How similar studies have gone: Prior studies show benefits of both vestibular-based and dual-task approaches, but there is limited direct comparison in chronic stroke; this trial investigates this gap.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Diagnosis of ischemic stroke.
* Stroke duration ≥6 months.
* Rhomberg scale
* MMSE ≥ 24
* Able to walk with or without assistive device.
* Able to understand commands
* Willing to participate and provide consent aged between 40-70 years.

Exclusion Criteria:

* Severe visual impairements which effect balance.
* Participants with acute or sub acute stroke \<6 moths.
* Uncontrolled hypertension
* Uncontrolled diabetes
* Other neurological disorders such as Parkinson's disease or multiple sclerosis and Alzheimer's
* Participation in any other interventional trail.

Where it's running

  • Armed Forces Institute of Rehabilitation Medicine Rawalpindi, Pakistan
    Rawalpindi, Pakistan
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.